These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4686378)

  • 21. Longitudinal studies of plasma aldosterone, corticosterone, deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone determined simultaneously in mother and child at birth and during the early neonatal period. I. Spontaneous delivery.
    Sippell WG; Becker H; Versmold HT; Bidlingmaier F; Knorr D
    J Clin Endocrinol Metab; 1978 Jun; 46(6):971-85. PubMed ID: 263476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. o,p'DDD therapy in invasive adrenocortical carcinoma.
    Becker D; Schumacher OP
    Ann Intern Med; 1975 May; 82(5):677-9. PubMed ID: 1137262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma.
    Bochner F; Lloyd HM; Roeser HP; Thomas MJ
    Med J Aust; 1969 Apr; 1(16):809-12. PubMed ID: 5769733
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical treatment of Cushing's disease.
    N Engl J Med; 1969 Oct; 281(15):846-7. PubMed ID: 5809521
    [No Abstract]   [Full Text] [Related]  

  • 25. Results of treatment in 108 patients with Cushing's syndrome.
    Orth DN; Liddle GW
    N Engl J Med; 1971 Jul; 285(5):243-7. PubMed ID: 4326256
    [No Abstract]   [Full Text] [Related]  

  • 26. Remission in Cushing's syndrome with o,p'-DDD.
    Southren AL; Tochimoto S; Strom L; Ratuschni A; Ross H; Gordon G
    J Clin Endocrinol Metab; 1966 Mar; 26(3):268-78. PubMed ID: 4286017
    [No Abstract]   [Full Text] [Related]  

  • 27. [Simultaneous determination of serum progesterone and 17 alpha-hydroxyprogesterone and its clinical application].
    Kojima M; Ri S; Miura K; Katogawa A
    Horumon To Rinsho; 1975 Aug; 23(8):823-30. PubMed ID: 1238201
    [No Abstract]   [Full Text] [Related]  

  • 28. Impaired mineralocorticoid hormone responses to adrenocorticotropin stimulation: additional characterization of heterozygosity for the 21-hydroxylase deficiency type of congenital adrenal hyperplasia.
    Pardini DP; Kater CE; Vieira JG; Biglieri EG
    J Clin Endocrinol Metab; 1983 Nov; 57(5):1061-6. PubMed ID: 6311859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dissociated effect of amino-glutethimide on the mineralocorticoid secretion in man.
    Mancheno-Rico E; Kuchel O; Nowaczynski W; Seth KK; Sasaki C; Dawson K; Genest J
    Metabolism; 1973 Feb; 22(2):123-32. PubMed ID: 4683523
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapy of a Cushing syndrome caused by hyperplasia of the adrenal cortex in a 7-year old girl with the adrenal cortex blocking agent opDDD ].
    Pichler E
    Helv Paediatr Acta; 1966 Nov; 21(5):447-74. PubMed ID: 5995803
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of the adrenal cortex blockader O,P'-dichlorodiphenyldichloroethane (O,P'-DDD) on the acetylation processes in the liver].
    Shevchenko AV; Kosbel' NN
    Vrach Delo; 1974 Jan; (1):72-4. PubMed ID: 4468586
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of 11beta-hydroxylase activity with plasma corticosterone, deoxycorticosterone, cortisol, and deoxycortisol: role of ACTH and angiotensin.
    Ganguly A; Meikle AW; Tyler FH; West CD
    J Clin Endocrinol Metab; 1977 Mar; 44(3):560-8. PubMed ID: 190262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism.
    Nelson RW; Feldman EC; Shinsako J
    Am J Vet Res; 1985 Jul; 46(7):1534-7. PubMed ID: 2992329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study.
    Hermsen IG; Fassnacht M; Terzolo M; Houterman S; den Hartigh J; Leboulleux S; Daffara F; Berruti A; Chadarevian R; Schlumberger M; Allolio B; Haak HR; Baudin E
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1844-51. PubMed ID: 21470991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy.
    Dörr HG; Heller A; Versmold HT; Sippell WG; Herrmann M; Bidlingmaier F; Knorr D
    J Clin Endocrinol Metab; 1989 May; 68(5):863-8. PubMed ID: 2715289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients.
    Hutter AM; Kayhoe DE
    Am J Med; 1966 Oct; 41(4):581-92. PubMed ID: 5923599
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of 11 beta-hydroxyprogesterone in biosynthesis of corticosterone from progesterone in guinea pig adrenals.
    Yudaev NA; Afinogenova SA
    Endocrinol Exp; 1975 Jun; 9(2):114-20. PubMed ID: 1079179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of 2,2-bis (2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane (o,p'-DDD) on the metabolism of infused cortisol-7-3H.
    Southren AL; Tochimoto S; Isurugi K; Gordon GG; Krikun E; Stypulkowski W
    Steroids; 1966 Jan; 7(1):11-29. PubMed ID: 5920859
    [No Abstract]   [Full Text] [Related]  

  • 39. Hydrocortisone suppression test for Cushing syndrome. Therapy with anticonvulsants.
    Meikle AW; Stanchfield JB; West CD; Tyler FH
    Arch Intern Med; 1974 Dec; 134(6):1068-71. PubMed ID: 4372963
    [No Abstract]   [Full Text] [Related]  

  • 40. Progesterone concentrations in the peripheral plasma of the blue fox (Alopex lagopus) during pregnancy and the oestrous cycle.
    Moller OM
    J Endocrinol; 1973 Dec; 59(3):429-38. PubMed ID: 4761680
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.